Sign up to save your podcasts
Or
Share Moderna’s Rise, JCP’s Split
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Moderna’s Rise, JCP’s Split
Moderna shares pop 20% on encouraging test results. JC Penney’s plan to survive involves splitting into two separate public companies: one for retail, one as a REIT. Bill Barker analyzes those stories as we dip into the Fool Mailbag to discuss retail and diversification.
View all episodes
By The Motley Fool
4.7
16081,608 ratings
Moderna shares pop 20% on encouraging test results. JC Penney’s plan to survive involves splitting into two separate public companies: one for retail, one as a REIT. Bill Barker analyzes those stories as we dip into the Fool Mailbag to discuss retail and diversification.
More shows like MarketFoolery
View all
Mad Money w/ Jim Cramer
4,084 Listeners
Investing Insights
497 Listeners
Motley Fool Money
3,195 Listeners
Industry Focus
826 Listeners
Masters in Business
2,174 Listeners
Money For the Rest of Us
1,362 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,368 Listeners
Motley Fool Answers
805 Listeners
InvestED: The Rule #1 Investing Podcast
1,489 Listeners
Rule Breaker Investing
937 Listeners
Invest Like the Best with Patrick O'Shaughnessy
2,317 Listeners
Bogleheads On Investing Podcast
592 Listeners
Investing With IBD
384 Listeners
The Long View
885 Listeners
Barron's Streetwise
1,546 Listeners
The Memo by Howard Marks
416 Listeners
The Investopedia Express with Caleb Silver
236 Listeners